I agree that this site is using cookies. You can find further informations here.
X
Markovets, Aleksandra A.
39  results:
Search for persons X
?
1

Mixed responses to targeted therapy driven by chromosomal i..:

Hobor, Sebastijan ; Al Bakir, Maise ; Hiley, Crispin T....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Candidate mechanisms of acquired resistance to first-line o..:

Chmielecki, Juliann ; Gray, Jhanelle E. ; Cheng, Ying...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
3

Author Correction: Candidate mechanisms of acquired resista..:

Chmielecki, Juliann ; Gray, Jhanelle E. ; Cheng, Ying...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
4

Longitudinal Circulating Tumor DNA Modeling to Predict Dise..:

Johnson, Martin ; Serra Traynor, Carlos ; Vishwanathan, Karthick...
Clinical Pharmacology & Therapeutics.  115 (2023)  2 - p. 349-360 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Molecular landscape of osimertinib resistance in patients a..:

Lim, Sun Min ; Yang, San-Duk ; Lim, Sangbin...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592210791 , 2022
Link: https://doi.org/10.1177/..
 
?
6

Osimertinib + Savolitinib to Overcome Acquired MET-Mediated..:

Hartmaier, Ryan J. ; Markovets, Aleksandra A. ; Ahn, Myung Ju...
Cancer Discovery.  13 (2022)  1 - p. 98-113 , 2022
Link: https://doi.org/10.1158/..
 
?
7

The landscape of therapeutic vulnerabilities in EGFR inhibi..:

Criscione, Steven W. ; Martin, Matthew J. ; Oien, Derek B....
npj Precision Oncology.  6 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
8

Clinical impact of subclonal EGFR T790M mutations in advanc..:

Vaclova, Tereza ; Grazini, Ursula ; Ward, Lewis...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
9

Programmed Cell Death Ligand 1 Expression in Untreated EGFR..:

Brown, Helen ; Vansteenkiste, Johan ; Nakagawa, Kazuhiko...
Journal of Thoracic Oncology.  15 (2020)  1 - p. 138-143 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Targeting melanoma's MCL1 bias unleashes the apoptotic pote..:

Sale, Matthew J. ; Minihane, Emma ; Monks, Noel R....
Nature Communications.  10 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
11

Epidermal growth factor receptor mutation analysis in tissu..:

Papadimitrakopoulou, Vassiliki A. ; Han, Ji‐Youn ; Ahn, Myung‐Ju...
Cancer.  126 (2019)  2 - p. 373-380 , 2019
Link: https://doi.org/10.1002/..
 
?
12

Acquired savolitinib resistance in non-small cell lung canc..:

Henry, Ryan E. ; Barry, Evan R. ; Castriotta, Lillian...
Oncotarget.  7 (2016)  36 - p. 57651-57670 , 2016
Link: https://doi.org/10.18632..
 
?
13

VarDict: a novel and versatile variant caller for next-gene..:

Lai, Zhongwu ; Markovets, Aleksandra ; Ahdesmaki, Miika...
Nucleic Acids Research.  44 (2016)  11 - p. e108-e108 , 2016
Link: https://doi.org/10.1093/..
 
?
14

Analysis of cancer metabolism with high-throughput technolo..:

Markovets, Aleksandra A ; Herman, Damir
BMC Bioinformatics.  12 (2011)  S10 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
15

Promoter prediction in E. coli based on SIDD profiles and A..:

Bland, Charles ; Newsome, Abigail S ; Markovets, Aleksandra A
BMC Bioinformatics.  11 (2010)  S6 - p. , 2010
Link: https://doi.org/10.1186/..
 
1-15